BackVirpax Pharmaceuticals Overview

Virpax Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for VRPX.

Quarterly EBIT

-$3.39M
↑ 27.64% YoY

As of Dec 31, 2024

Annual EBIT (TTM)

-$15.38M
↑ 2.06% YoY

Trailing 12 months ending Dec 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin